Lack of difference among progestins on the anti-atherogenic effect of ethinyl estradiol: A rabbit study

Human Reproduction

Volumn 18, Issue 7, 2003, Pages 1395-1403

  Alexandersen, Peter ^a   Haarbo, Jens ^a   Zandberg, Pieter ^b   Jespersen, Jørgen ^a   Skouby, Sven O ^a   Christiansen, Claus ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^b NV ORGANON   (Netherlands)

Author keywords

Atherosclerosis; Estrogen; Progestins; Rabbits; Vascular reactivity

Indexed keywords

ACETYLCHOLINE; DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; GESTODENE; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; PLACEBO; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; AREA UNDER THE CURVE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CHOLESTEROL DIET; CHOLESTEROL METABOLISM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG POTENTIATION; DRUG RESPONSE; FEMALE; IN VITRO STUDY; NONHUMAN; OVARIECTOMY; RABBIT; SEXUAL MATURITY;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0038639918     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deg286     Document Type: Article

References (38)

1. Alexandersen, P., Haarbo, J., Sandholdt, I., Shalmi, M., Lawaetz, H. and Christiansen, C. (1998) Norethindrone acetate enhances the antiatherogenic effect of 17beta-estradiol: A secondary prevention study of aortic atherosclerosis in ovariectomized cholesterol-fed rabbits. Arterioscler. Thromb. Vasc. Biol., 18, 902-907.
2. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
3. Cheung, M.C., Walden, C.E. and Knopp, R.H. (1999) Comparison of the effects of triphasic oral contraceptives with desogestrel or levonorgestrel on apolipoprotein A-I-containing high density lipoprotein particles. Metabolism, 48, 648-664.
4. Crook D. and Godsland, I. (1998) Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism. Contraception, 57, 189-201.
5. Dunn, N.R., Faragher, B., Thorogood, M., De Caestecker, L., MacDonald, T.M., McCollum, C., Thomas, S. and Mann, R. (1999) Risk of myocardial infarction in young female smokers. Heart, 82, 581-583.
6. Dunn, N.R., Arscott, A. and Thorogood, M. (2001) The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: Results from the MICA case-control study. Contraception, 63, 65-69.
7. Farley, T.M., Meirik, O., Chang, C.L. and Poulter, N.R. (1998) Combined oral contraceptives, smoking, and cardiovascular risk. J. Epidemiol. Community Health, 52, 775-785.
8. Farley, T.M., Meirik, O. and Collins, J. (1999) Cardiovascular disease and combined oral contraceptives: Reviewing the evidence and balancing the risks. Hum. Reprod. Update, 5, 721-735.
9. Furchgott, R.F. and Zawadzki, J.V. (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
10. GeversLeuven, J.A., Dersjant-Roorda, M.C., Helmerhorst, F.M., De Boer, R., Neymeyer-Leloux, A. and Havekes, L. (1990) Estrogenic effect of gestodene- or desogestrel-containing oral contraceptives on lipoprotein metabolism. Am. J. Obstet. Gynecol., 163 (1 Pt 2), 358-362.
11. Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Kha, S. et al. (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). J. Am. Med. Assoc., 288, 49-57.
12. Haarbo, J., Leth-Espensen, P., Stender, S. and Christiansen, C. (1991) Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J. Clin. Invest., 87, 1274-1279.
13. Haarbo, J., Svendsen, O.L. and Christiansen, C. (1992) Progestogens do not affect aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. Circ. Res., 70, 1198-1202.
14. Herkert, O., Kuhl, H., Busse, R. and Schini-Kerth, V.B. (2000) The progestin levonorgestrel induces endothelium-independent relaxation of rabbit jugular vein via inhibition of calcium entry and protein kinase C: Role of cyclic AMP. Br. J. Pharmacol., 130, 1911-1918.
15. Janne, O.A., Zook, B.C., Didolkar, A.K., Sundaram, K. and Nash, H.A. (2001) The roles of estrogen and progestin in producing deciduosarcoma and other lesions in the rabbit. Toxicol. Pathol., 29, 417-421.
16. Jick, H., Jick, S., Myers, M.W. and Vasilakis, C. (1996) Risk of acute myocardial infarction and low-dose combined oral contraceptives (research letter). Lancet, 347, 627-628.
17. Kaplan, J.R., Adams, M.R., Anthony, M.S., Morgan, T.M., Manuck, S.B. and Clarkson, T.B. (1995) Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys. Arterioscler. Thromb. Vasc. Biol., 15, 2094-2100.
18. Kook, K., Gabelnick, H. and Duncan, G. (2002) Pharmacokinetics of levonorgestrel 0.75 mg tablets. Contraception, 66, 73-76.
19. Kuhl, H. (1996) Comparative pharmacology of newer progestogens. Drugs, 51, 188-215.
20. Kuhl, H., Marz, W., Jung-Hoffmann, C., Heidt, F. and Gross, W. (1990) Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives. Am. J. Obstet. Gynecol., 163 (1 Pt 2), 363-369.
21. Leuven, J.A., Dersjant-Roorda, M.C., Helmerhorst, F.M., De Boer, R., Neymeyer-Leloux, A. and Havekes, L.M. (1908) Effects of oral contraceptives on lipid metabolism. Am. J. Obstet. Gynecol., 163 (4 Pt 2), 1410-1413.
22. Lewis, M.A. (1998) Myocardial infarction and stroke in young women: What is the impact of oral contraceptives? Am. J. Obstet. Gynecol., 179, S68-S77.
23. Lewis, M.A., Spitzer, W.O., Heinemann, L.A., MacRae, K.D., Bruppacher, R. and Thorogood, M. (1996) Third generation oral contraceptives and risk of myocardial infarction: An international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. Br. Med. J., 312, 88-90.
24. Lewis, M.A., Heinemann, L.A., Spitzer, W.O., MacRae, K.D. and Bruppacher, R. (1997) The use of oral contraceptives and the occurrence of acute myocardial infarction in young women: Results from the Transnational study on oral contraceptives and the health of young women. Contraception, 56, 129-40.
25. Lobo, R.A., Skinner, J.B., Lippman, J.S. and Cirillo, S.J. (1996) Plasma lipids and desogestrel and ethinyl estradiol: A meta-analysis. Fertil. Steril., 65, 1100-1109.
26. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein measurement with folin phenol reagent. J. Biol. Chem., 193, 265-275.
27. Petitti, D.B., Sidney, S. and Quesenberry, C.P. Jr (2000) Hormone replacement therapy and the risk of myocardial infarction in women with coronary risk factors. Epidemiology, 11, 603-606.
28. Poulter, N.P., Chang, C.L., Farley, T.M.M., Kelaghan, J., Meirlk O. and Marmot, M.G. (1997) Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet, 349, 1202-1209.
29. Rosendaal, F.R., Helmerhorst, F.M. and Vandebroucke, J.P. (2002) Female hormones and thrombosis. Arterioscler. Thromb. Vasc. Biol., 22, 201-210.
30. Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Beresford, S.A., Howard, B.V., Johnson, K.C. et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. J. Am. Med. Assoc., 288, 321-333.
31. Sidney, S., Siscovick, D.S., Petitti, D.B., Schwartz, S.M., Quesenberry, C.P., Psaty, B.M., Raghunathan, T.E., Kelaghan, J. and Koepsell, T.D. (1998) Myocardial infarction and use of low-dose oral contraceptives: A pooled analysis of 2 US studies. Circulation, 98, 1058-1063.
32. Sulistiyani, Adelman, S.J., Chandrasekaran, A., Jayo, J. and St. Clair, R.W. (1995) Effect of 17 alpha-dihydroequilin sulfate, a conjugated equine estrogen, and ethinylestradiol on atherosclerosis in cholesterol-fed rabbits. Arterioscler. Thromb. Vasc. Biol., 15, 837-846.
33. Tanis, B.C., Van Den Bosch, M.A. Kemmeren, J.M., Cats, V.M., Helmerhorst, F.M., Algra, A., Van Der Graaf, Y. and Rosendaal, F.R. (2001) Oral contraceptives and the risk of myocardial infarction. N. Engl. J. Med., 345, 1787-1793.
34. Thorpe, S.M. (1987) Steroid receptors in breast cancer: Sources of inter-laboratory variation in dextran-choarcoal assays. Breast Cancer Res. Treat., 9, 175-189.
35. Thorpe, S.M., Lykkesfeldt, A.E., Vinterby, A. and Londorfer, M. (1986) Quantitative immunological detection of estrogen receptors in nuclear pellets from human breast cancer biopsies. Cancer Res., 46, 4251S-4255S.
36. VanderVies, J. and De Visser, J. (1983) Endocrinological studies with desogestrel. Arzneimittelforschung, 33, 231-236.
37. World Health Organization (1997) Details?
38. Zandberg, P., Peters, J.L.M., Demacker, P.N., De Reeder, E.G., Smit, M.J. and Meuleman, D.G. (2001) Comparison of the antiatherosclerotic effect of tibolone with that of estradiol and ethinyl estradiol in cholesterol-fed, ovariectomized rabbits. Menopause, 8, 96-105.